Biogen BIIB
NASDAQ BIIB
$217.15 +1.72 (+0.80%)
As of: Sep 11, 2026 · 3:59 PM EDT

Biogen (BIIB) Goodwill & Intangibles (2009 - 2026)

Biogen (BIIB) posted Goodwill & Intangibles of $20.5 billion for Q2 2026, up 31.95% on a QoQ basis from $15.5 billion in Q1 2026, and up 28.49% year-over-year from $16.0 billion in Q2 2025.

Analysis

Biogen (BIIB) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Biogen has reported Goodwill & Intangibles for 18 years, with the latest figure at $20.5 billion in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles rose 28.49% year-over-year to $20.5 billion in Q2 2026; TTM through Jun 2026 was $20.5 billion, a 28.49% increase from a year earlier, with the FY2025 full-year figure at $15.7 billion, down 3.1% from the prior year.
  • Goodwill & Intangibles was $20.5 billion for Q2 2026 at Biogen, up from $15.5 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $20.5 billion in Q2 2026, with the low at $7.5 billion in Q2 2023.
  • Average Goodwill & Intangibles over 5 years is $13.1 billion, with a median of $14.5 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles retreated 9.63% in 2022, then surged 92.03% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $7.6 billion in 2022, then jumped by 91.89% to $14.6 billion in 2023, then grew by 10.89% to $16.2 billion in 2024, then slipped by 3.1% to $15.7 billion in 2025, then jumped by 30.87% to $20.5 billion in 2026.
  • The last three Goodwill & Intangibles figures came in at $20.5 billion (Q2 2026), $15.5 billion (Q1 2026), and $15.7 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Insmed 28.06 Bn 26.90 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.51 Bn
Mar 31, 2026 15.54 Bn
Dec 31, 2025 15.67 Bn
Sep 30, 2025 15.82 Bn
Jun 30, 2025 15.96 Bn
Mar 31, 2025 16.06 Bn
Dec 31, 2024 16.17 Bn
Sep 30, 2024 16.29 Bn
Jun 30, 2024 14.46 Bn
Mar 31, 2024 14.51 Bn
Dec 31, 2023 14.58 Bn
Sep 30, 2023 14.15 Bn
Jun 30, 2023 7.53 Bn
Mar 31, 2023 7.57 Bn
Dec 31, 2022 7.60 Bn
Sep 30, 2022 7.75 Bn
Jun 30, 2022 7.82 Bn
Mar 31, 2022 7.91 Bn
Dec 31, 2021 7.98 Bn
Sep 30, 2021 8.05 Bn